Leadership Needed

Neuroscientist Ira B. Black: "So many of the diseases facing us involve behavioral patterns." A search committee will stop accepting applications for the directorship of the newly chartered Office of Behavioral and Social Sciences Research (OBSSR) at the National Institutes of Health this week. The deadline's passing sets the stage for the appointment, by year's end, of a leader whose task will be to effective- ly integrate behavior

Written byFranklin Hoke
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Advocates who have long struggled to raise the stature of these disciplines at NIH succeeded through pressure and persuasion in getting Congress to write the new office into the health agency's fiscal 1994 authorization. Now, they say that if a strong first director is named, OBSSR should be able to promote in-novative, interdisciplinary re- search that will significantly extend understandings of basic processes in disease and health.

Some of these observers voice concerns, however, that OBSSR may not be easily incorporated into the laboratory sciences culture that prevails at NIH. The office's most important potential ally, NIH director Harold Varmus, has expressed, at best, lukewarm support for the behavioral and social sciences, they say.

Although the new OBSSR director will have a high profile-- the position will carry the additional title of associate director of NIH and will reside within the NIH director's office--how the office fares will depend, in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies